NEWS RELEASE 11-JUL-2024 Analysis of more than 1.5 million records of patients with type 2 diabetes casts light on the risk of dementia and Alzheimer’s disease and potential benefits associated with antidiabetic treatment, reports the American Journal of Preventive Medicine Peer-Reviewed PublicationELSEVIER IMAGE: RESULTS SHOW THAT THE FIRST-LINE ANTIDIABETIC DRUG METFORMIN AND THE SECOND-LINE SODIUM...
